alpha-(4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol;an agonist at gamma-aminobutyric acid (gABA) type A receptors. Unlike other agonists of this type, upon systemic administration tHIP penetrates the blood-brain barrier and is used as a pharmacological tool to explore gABA receptor function in the brain and spinal cord.

Please contribute to this project, if you have more information about this term feel free to edit this page

This page was last modified on 3 October 2005, at 21:16. This page has been accessed 764 times. 
What links here | Related changes | Permanent link